Friday, April 23, 2021

Tag: Drug Administration

StemCyte Receives Phase II Investigational New Drug (IND) Clearance from the U.S. Food and...

BALDWIN PARK, Calif., Jan. 3, 2019 /PRNewswire/ -- StemCyte is pleased to announce that the U.S. Food and Drug Administration (FDA), on December 14, 2018, approved its Phase II Investigational New Drug (IND) application for...

Q Therapeutics Approved to Start Trial of Cell Therapy Aiming to Restore Myelin

A cell therapy intended to boost myelin regeneration — Q-Cells by Q Therapeutics — has received a green light from the U.S. Food and Drug Administration to proceed with a clinical trial in patients with transverse myelitis (TM), a...

Asterias Biotherapeutics Receives FDA Clearance to Enroll C-4 Patients in SCiStar Study

Ability to enroll patients with second most common cervical spinal cord injury broadens eligible population for SCiStar study and future trials FREMONT, Calif., July 10, 2017 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a...

Lyrica Approved for Spinal Neuropathic Pain

The Food and Drug Administration has approved the use of Lyrica for the management of neuropathic pain associated with chronic, debilitating spinal cord injuries. Lyrica, the brand name for pregabalin, is manufactured by Pfizer...

Promising new therapy could ‘cure’ paralyzed patients

Dr. W. Dalton Dietrich, scientific director of the Miami Project to Cure Paralysis, was in Washington this week seeking U.S. Food and Drug Administration approval to start a clinical safety trial of a remarkable...

China halts unapproved stem cell treatments as industry grows in country with lighter rules

BEIJING — The Health Ministry ordered unapproved stem cell treatments stopped Tuesday as China tries to bring under control its growing but loosely regulated industry. The ministry stopped accepting applications for stem cell procedures until...

Geron Is Shutting Down Its Stem Cell Clinical Trial

The company conducting the world’s first clinical trial of a therapy using human embryonic stem cells said on Monday that it was halting that trial and leaving the stem cell business entirely. The company, Geron,...